Video Game Play to Alleviate Adolescent Anxiety
Launched by SCHOOL OF HEALTH SCIENCES GENEVA · Jun 20, 2023
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how playing different types of video games can help reduce anxiety in adolescents aged 12 to 14 years. Researchers want to see if action video games, which require quick thinking and attention, are more effective at easing anxiety compared to casual video games, which are more relaxed and fun. The study will involve three groups: one group will play action games, another will play casual games, and a third group will not play any games at all. The goal is to see if playing these games for six weeks can help lower anxiety symptoms when done from home.
To participate, teens must be between 12 and 14 years old and have a high score on a specific anxiety questionnaire, indicating they experience significant anxiety. They also need to have access to a computer and a reliable internet connection. However, those with certain mental health diagnoses or neurological injuries cannot join. Participants can look forward to engaging in video game sessions and contributing to important research that could help others dealing with anxiety.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adolescents aged 11-15 years
- • 2. High-anxious score from the 41 items SCARED-Parent version (i.e. total score equal or above 17)
- • 3. Access to a computer (at least Windows 7 or Mac OSX) at home and a reliable internet connection
- Exclusion Criteria:
- • 1. DSM diagnoses of Bipolar, Psychosis, Autism Spectrum Disorder, present or past.
- • 2. Neurological injury (i.e. head injury)
- • 3. Currently enrolled in another cognitive training intervention
About School Of Health Sciences Geneva
The School of Health Sciences Geneva is a leading academic institution dedicated to advancing healthcare through innovative research and education. With a strong emphasis on interdisciplinary collaboration, the School engages in clinical trials that aim to explore and enhance health outcomes across diverse populations. Committed to ethical standards and scientific rigor, the School fosters an environment that encourages the development of new therapies and health interventions, ultimately contributing to the global body of knowledge in health sciences. Through partnerships with clinical practitioners and research organizations, the School of Health Sciences Geneva is at the forefront of addressing pressing health challenges and improving patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Haifa, , Israel
Geneva, , Switzerland
Patients applied
Trial Officials
Daphné Bavelier, Professor
Principal Investigator
University of Geneva, Switzerland
Swann Pichon, Professor
Principal Investigator
HES - Geneva School of Health Science, Switzerland
Tomer Shechner, Professor
Principal Investigator
University of Haifa, Israel
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported